同步放疗与纳武单抗治疗前列腺异时性转移性原发性腺鳞癌 - Suppr

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate.

作者信息

Eze Chukwuka, Manapov Farkhad, Gratzke Christian, Schmidt-Hegemann Nina-Sophie, Jung Andreas, Kirchner Thomas, Heinemann Volker, Stief Christian G, Belka Claus, Boeck Stefan

机构信息

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

出版信息

Eur J Cancer. 2018 May;95:109-111. doi: 10.1016/j.ejca.2018.01.086. Epub 2018 Feb 21.

DOI:10.1016/j.ejca.2018.01.086

PMID:29477368

Abstract

摘要

相似文献

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate.同步放疗与纳武单抗治疗前列腺异时性转移性原发性腺鳞癌

Eur J Cancer. 2018 May;95:109-111. doi: 10.1016/j.ejca.2018.01.086. Epub 2018 Feb 21.

[Lung Adenosquamous Cell Carcinoma in which the Administration of Nivolumab Became Untenable due to Bleeding from Small Intestine Metastasis].[因小肠转移出血导致纳武单抗治疗无法进行的肺腺鳞癌]

Kyobu Geka. 2018 Oct;71(11):948-951.

Nivolumab plus ipilimumab in metastatic colorectal cancer.纳武利尤单抗联合伊匹木单抗治疗转移性结直肠癌

Lancet Oncol. 2018 Mar;19(3):e139. doi: 10.1016/S1470-2045(18)30067-6. Epub 2018 Jan 26.

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation.转移性透明细胞肾细胞癌的免疫基因组学：一名携带致病性种系BRCA1突变患者对纳武单抗的显著反应。

Clin Genitourin Cancer. 2019 Oct;17(5):e909-e912. doi: 10.1016/j.clgc.2019.06.013. Epub 2019 Jul 11.

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety.纳武利尤单抗治疗晚期转移性非小细胞肺癌的日本患者：疗效和安全性临床试验证据的综述。

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618801167. doi: 10.1177/1753466618801167.

Multiple Cranial Neuropathies From Nivolumab in a Patient With Metastatic Hepatocellular Carcinoma.纳武单抗致转移性肝细胞癌患者多发颅神经病变

Mayo Clin Proc. 2018 Apr;93(4):540-541. doi: 10.1016/j.mayocp.2018.01.001.

Nivolumab for the treatment of urothelial cancers.纳武利尤单抗治疗尿路上皮癌。

Expert Rev Anticancer Ther. 2018 Mar;18(3):215-221. doi: 10.1080/14737140.2018.1432357. Epub 2018 Jan 31.

Checkpoint Inhibitors May Cause Pseudoprogression and Dose-Limiting Side Effects.检查点抑制剂可能会导致假性进展和剂量限制性副作用。

ONS Connect. 2016 Jul;31(7):24.

Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.免疫检查点抑制剂（纳武利尤单抗）相关肾损伤以及识别已知可引起急性肾小管间质性肾炎的伴随用药的重要性：一例报告

BMC Nephrol. 2018 Feb 27;19(1):48. doi: 10.1186/s12882-018-0848-y.

Nivolumab-Associated Colitis Mimicking Ulcerative Colitis.模仿溃疡性结肠炎的纳武利尤单抗相关性结肠炎。

Clin Gastroenterol Hepatol. 2017 Sep;15(9):A35-A36. doi: 10.1016/j.cgh.2017.03.026. Epub 2017 Mar 27.

引用本文的文献

The diagnostic dilemma of squamous differentiation in prostate cancer: A case report.前列腺癌中鳞状分化的诊断困境：一例报告

Urol Case Rep. 2025 Apr 4;60:103034. doi: 10.1016/j.eucr.2025.103034. eCollection 2025 May.

Adenosquamous carcinoma of the prostate with low PSMA expression.前列腺腺鳞癌伴低前列腺特异性膜抗原（PSMA）表达。

Int Urol Nephrol. 2023 Mar;55(3):613-615. doi: 10.1007/s11255-022-03428-6. Epub 2022 Dec 20.

Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.前列腺腺鳞癌循环肿瘤细胞的基因组分析：一例报告。

BMC Med Genomics. 2021 Sep 3;14(1):217. doi: 10.1186/s12920-021-01068-w.

rs4143815-, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy.rs4143815-，一种新的潜在免疫遗传生物标志物，可预测局部晚期前列腺癌放疗后生化复发。

Int J Mol Sci. 2019 Apr 27;20(9):2082. doi: 10.3390/ijms20092082.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献